​
​

Axonics (AXNX) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

Axonics Revenue Highlights

Latest Revenue (Y)

$366.38M

Latest Revenue (Q)

$116.19M

Main Segment (Y)

Sacral Neuromodulation

Main Geography (Y)

UNITED STATES

Axonics Revenue by Period

Axonics Revenue by Year

DateRevenueChange
2023-12-31-33.86%
2022-12-31-51.81%
2021-12-31-61.64%
2020-12-31-707.05%
2019-12-31-1854.74%
2018-12-31-451.84%
2017-12-31-100.00%
2016-12-31--

Axonics generated $366.38M in revenue during NA 2023, up 33.86% compared to the previous quarter, and up 51821.64% compared to the same period a year ago.

Axonics Revenue by Quarter

DateRevenueChange
2024-09-30-1.42%
2024-06-30-25.33%
2024-03-31--16.70%
2023-12-31-17.87%
2023-09-30-310.06%
2023-06-30--67.86%
2023-03-31--17.77%
2022-12-31-22.07%
2022-09-30-2.04%
2022-06-30-42.46%
2022-03-31--8.87%
2021-12-31-13.26%
2021-09-30-2.28%
2021-06-30-33.44%
2021-03-31--1.18%
2020-12-31--1.31%
2020-09-30-131.66%
2020-06-30--42.15%
2020-03-31-164.39%
2019-12-31-659.82%
2019-09-30--12.03%
2019-06-30-38.16%
2019-03-31-118.02%
2018-12-31-145.77%
2018-09-30-1575.00%
2018-06-30-100.00%
2018-03-31--100.00%
2017-12-31--99.91%
2017-09-30-100.00%
2017-06-30-100.00%
2017-03-31--

Axonics generated $116.19M in revenue during Q3 2024, up 1.42% compared to the previous quarter, and up 511.77% compared to the same period a year ago.

Axonics Revenue Breakdown

Axonics Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 23
Sacral Neuromodulation-
Bulkamid-

Axonics's latest annual revenue breakdown by segment (product or service), as of Dec 23: Sacral Neuromodulation (79.65%), and Bulkamid (20.35%).

Quarterly Revenue by Product

Product/ServiceSep 24Jun 24Mar 24Dec 23Sep 23Jun 21Mar 21
Sacral Neuromodulation-------
Bulkamid-------

Axonics's latest quarterly revenue breakdown by segment (product or service), as of Sep 24: Sacral Neuromodulation (79.48%), and Bulkamid (20.52%).

Axonics Revenue Breakdown by Country

Annual Revenue by Country

CountryDec 23Dec 22Dec 21Dec 20Dec 19
Non-US-----
UNITED STATES-----

Axonics's latest annual revenue breakdown by geography, as of Dec 23: UNITED STATES (94.83%), and Non-US (5.17%).

Quarterly Revenue by Country

CountrySep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20
UNITED STATES-------------------
Non-US-------------------

Axonics's latest quarterly revenue breakdown by geography, as of Sep 24: UNITED STATES (94.95%), and Non-US (5.05%).

Axonics Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
MDTMedtronic--
BRKRBruker--
ITGRInteger--
IARTIntegra LifeSciences--
CNMDCONMED--
LIVNLivaNova--
IRTCiRhythm--
AXNXAxonics--
GKOSGlaukos--
KIDSOrthoPediatrics--
SIBNSI-BONE--
LUNGPulmonx--
NPCENeuroPace--
NNOXNano-X Imaging--
MGRMMonogram Orthopaedics--
OFIXOrthofix Medical--

AXNX Revenue FAQ

What is Axonics’s yearly revenue?

Axonics's yearly revenue for 2023 was $366.38M, representing an increase of 33.86% compared to 2022. The company's yearly revenue for 2022 was $273.7M, representing an increase of 51.81% compared to 2021. AXNX's yearly revenue for 2021 was $180.29M, representing an increase of 61.64% compared to 2020.

What is Axonics’s quarterly revenue?

Axonics's quarterly revenue for Q3 2024 was $116.19M, a 1.42% increase from the previous quarter (Q2 2024), and a 24.80% increase year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $114.56M, a 25.33% increase from the previous quarter (Q1 2024), and a 404.60% increase year-over-year (Q2 2023). AXNX's quarterly revenue for Q1 2024 was $91.41M, a -16.70% decrease from the previous quarter (Q4 2023), and a 29.38% increase year-over-year (Q1 2023).

What is Axonics’s revenue growth rate?

Axonics's revenue growth rate for the last 3 years (2021-2023) was 103.22%, and for the last 5 years (2019-2023) was 2551.08%.

What are Axonics’s revenue streams?

Axonics's revenue streams in c 23 are Sacral Neuromodulation, and Bulkamid. Sacral Neuromodulation generated $291.8M in revenue, accounting 79.65% of the company's total revenue Bulkamid generated $74.57M in revenue, accounting 20.35% of the company's total revenue

What is Axonics’s main source of revenue?

For the fiscal year ending Dec 23, the largest source of revenue of Axonics was Sacral Neuromodulation. This segment made a revenue of $291.8M, representing 79.65% of the company's total revenue.